Streptococcus pneumoniae protein vaccine candidates: Properties, activities and animal studies

Critical Reviews in Microbiology

Volumn 32, Issue 3, 2006, Pages 139-153

  Tai, Stanley S ^a,b  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HOWARD UNIVERSITY   (United States)

Author keywords

Protein; S. pneumoniae; Vaccine

Indexed keywords

AUTOLYSIN; BACTERIAL PROTEIN; HYBRID PROTEIN; IRON BINDING PROTEIN; IRON TRANSPORT PROTEIN PIAA; IRON TRANSPORT PROTEIN PIUA; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; PNEUMOCOCCAL HISTIDINE TRIAD PROTEIN; PNEUMOCOCCAL PROTECTIVE PROTEIN A; PNEUMOCOCCAL SURFACE ANTIGEN; PNEUMOCOCCAL SURFACE PROTEIN A; PNEUMOCOCCAL SURFACE PROTEIN C; PNEUMOCOCCUS VACCINE; PNEUMOLYSIN; PNEUMOLYSIN ANTIBODY; PROTEIN ANTIBODY; PROTEIN LYTB; PROTEIN LYTC; PROTEIN NANA; PROTEIN NANB; PROTEIN PHTA; PROTEIN PHTB; PROTEIN PHTD; PROTEIN PHTE; PROTEIN PSAA ANTIBODY; PROTEIN PSPA ANTIBODY; PROTEIN PSPC ANTIBODY; SIALIDASE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBODY PRODUCTION; BACTERIUM ISOLATION; BIOCHEMISTRY; COMMUNITY ACQUIRED PNEUMONIA; DRUG ACTIVITY; DRUG DESIGN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINE PRODUCTION;

ADHESINS, BACTERIAL; ANIMALS; BACTERIAL PROTEINS; BACTERIAL VACCINES; DISEASE MODELS, ANIMAL; LIPOPROTEINS; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; NEURAMINIDASE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

ANIMALIA; STREPTOCOCCUS PNEUMONIAE;

EID: 33747098189     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.1080/10408410600822942     Document Type: Review

References (112)

1. Adamou, J.E., Heinrichs, J.H., Erwin, A.L., Walsh, W., Gayle, T., Dormitzer, M., Dagan, R., Brewah, Y.A., Barren, P., Lathigra, R., Langermann, S., Koenig, S., and Johnson, S. 2001. Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect. Immun. 69, 949-958.
2. Advisory Committee on Immunization Practices. 2000. Preventing pneumococcal disease among infants and young children. Morbid. Mortal. Weekly Rep. 49 No RR09, 1-55.
3. Advisory Committee on Immunization Practices. 1989. Pneumococcal polysaccharide vaccine. Morbid. Mortal. Weekly Rep. 38, 64-76.
4. Alexander, J.E., Lock, R.A., Peeters, C.A.M., Poolman, J.T., Andrew, P.W., Mitchell, T.J., Hansman, D., and Paton, J.C. 1994. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect. Immun. 62, 5683-5688.
5. Arulanandam, B.P., Lynch, J.M., Briles, D.E., Hollingshead, S., and Metzger, D.W. 2001. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae Infection. Infect. Immun. 69, 6718-6724.
6. Balachandran, P., Brooks-Walter, A., Virolainen-Julkunen, A., Hollingshead, S.K., and Briles, D.E. 2002. Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect. Immun. 70, 2526-2534.
7. Balachandran, P., Hollingshead, S.K., Paton, J.C., and Briles, D.E. 2001. The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin. J. Bacteriol. 183, 3108-3116.
8. Beall, B., Gherardi, G., Facklam, R.R., and Hollingshead, S.K. 2000. Pneumococcal pspA sequence types of prevalent multiresistant pneumococcal strains in the United States and of internationally disseminated clones. J. Clin. Microbiol. 38, 3663-3669.
9. Berry, A.M., Lock, R.A., Hansman, D., and Paton, J.C. 1989. Contribution of autolysin to virulence of Streptococcus pneumoniae. Infect. Immun. 57, 2324-2330.
10. Berry, A.M., and Paton, J.C. 2000. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect. Immun. 68, 133-140.
11. Berry, A.M., and Paton, J.C. 1996. Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae. Infect. Immun. 64, 5255-5262.
12. Boulnois, G.J., Paton, J.C., Mitchell, T.J., and Andrew, P.W. 1991. Structure and function of pneumolysin, the multifunctional, thiol-activated toxin of Streptococcus pneumoniae. Mol. Microbiol. 5, 2611-2616.
13. Brandileone, M.C., Andrade, A.L., Teles, E.M., Zanella, R.C., Yara, T.I., Di Fabio, J.L., and Hollingshead, S.K. 2004. Typing of pneumococcal surface protein A (PspA) in Streptococcus pneumoniae isolated during epidemiological surveillance in Brazil:Towards novel pneumococcal protein vaccines. Vaccine. 22, 3890-3896.
14. Briles, D.E., Ades, E., Paton, J.C., Sampson, J.S., Carlone, G.M., Huebner, R.C., Virolainen, A., Swiatlo, E., and Hollingshead, S.K. 2000a. Intranasal immunization ofmice with amixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect. Immun. 68, 796-800.
15. Briles, D.E., Hollingshead, S., Brooks-Walter, A., Nabors, G.S., Ferguson, L., Schilling, M., Gravenstein, S., Braun, P., King, J., and Swift, A. 2000b. The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. Vaccine 18, 1707-1711.
16. Briles, D.E., Hollingshead, S.K., King, J., Swift, A., Braun, P.A., Park, M.K., Ferguson, L.M., Nahm, M.H., and Nabors, G.S. 2000c. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infectionwith Streptococcus pneumoniae bearing heterologous PspA. J. Infect. Dis. 182, 1694-1701.
17. Briles, D.E., Hollingshead, S.K., Nabors, G.S., Paton, J.C., and Brooks-Walter, A. 2000d. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae. Vaccine. 19 (Suppl 1), S87-S95.
18. Briles, D.E., Hollingshead, S.K., Paton, J.C.,Ades, E.W.,Novak, L., van Ginkel, F.W., and Benjamin Jr., W.H. 2003. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J. Infect. Dis. 188, 339-348.
19. Briles, D.E., King, J.D., Gray, M.A., McDaniel, L.S., Swiatlo, E., and Benton, K.A. 1996. PspA, a protection-eliciting pneumonoccal protein: Immunogenicity of isolated native PspA in mice. Vaccine. 14, 858-867.
20. Briles, D.E., Tart, R.C., Swiatlo, E., Dillard, J.P., Smith, P., Benton, K.A., Ralph, B.A., Brooks-Walter, A., Crain, M.J., Hollingshead, S.K., and McDaniel, L.S. 1998. Pneumococcal diversity: Considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (Pspa). Clin. Mircobiol. Rev. 11, 645-657.
21. Brooks-Walter, A., Briles, D.E., and Hollingshead, S.K. 1999. The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect. Immun. 67, 6533-6542.
22. Brown, J.S., Gilliand, S.M., and Holden, D.W. 2001a. A Streptococcus pneumoniae pathogenecity island encoding an ABC transporter involved in iron uptake and virulence. Mol. Microbiol. 40, 572-585.
23. Brown, J.S., Gilliland, S.M., Ruiz-Albert, J., and Holden, D.W. 2002. Characterization of pit, a Streptococcus pneumoniae iron uptake ABC transporter. Infect. Immun. 70, 4389-4398.
24. Brown, J.S., Ogunniyi, A.D., Woodrow, M.C., Holden, D.W., and Paton, J.C. 2001b. Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection. Infect. Immun. 69, 6702-6706.
25. Camara, M., Boulnois, G.J., Andrew, P.W., and Mitchell, T.J. 1994. A neuraminidase from Streptococcus pneumoniae has the features of a surface protein. Infect. Immun. 62, 3688-3695.
26. Camara,M., Mitchell, T.J., Andrew, P.W., and Boulnois, G.J. 1991. Streptococcus pneumoniae produces at least two distinct enzymes with neuraminidase activity: Cloning and expression of a second neuraminidase gene in Escherichia coli. Infect. Immun. 59, 2856-2858.
27. Cheng, Q., Finkel, D., and Hostetter, M.K. 2000. Novel purification scheme and functions for a C3-binding protein from Streptococcus pneumoniae. Biochemistry 39, 5450-5457.
28. Cima-Cabal, M.D., Vazquez, F., de, Jr, T.I., and Mendez, F.J. 1999. Rapid and reliable identification of Streptococcus pneumoniae isolates by pneumolysin-mediated agglutination. J. Clin. Microbiol. 37, 1964-1966.
29. Cundell, D.R., Weiser, J.N., Shen, J., Young, A., and Tuomanen, E.I. 1995. Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect. Immun. 63, 757-761.
30. Dagan, R., Kayhty, H., Wuorimaa, T., Yaich, M., Bailleux, F., Zamir, O., and Eskola, J. 2004. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants. Pediatr. Infect. Dis. J. 23, 91-98.
31. Dave, S., Brooks-Walter, A., Pangburn, M.K., and McDaniel, L.S. 2001. PspC, a pneumococcal surface protein, binds human factor H. Infect. Immun. 69, 3435-3437.
32. Dave, S., Pangburn, M.K., Pruitt, C., and McDaniel, L.S. 2004. Interaction of human factor H with PspC of Streptococcus pneumoniae. Indian J. Med. Res. 119, Suppl: 66-73.
33. de los Toyos, J.R., Memdez, F.J., Aparocio, J.F., Vazquez, F., del Mar Garcia Suarez, M., Feleites, A., Hardisson, C., Morgan, P.J., Andrew, P.W., and Mitchell, T.J. 1996. Functional analysis of pneumolysin by use of monoclonal antibodies. Infect. Immun. 64, 480-484.
34. Dintilhac, A., Alloing, G., Granadel, C., and Claverys, J.P. 1997. Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases. Mol. Microbiol. 25, 727-739.
35. Elm, C., Rohde, M., Vaerman, J.P., Chhatwal, G.S., and Hammerschmidt, S. 2004. Characterization of the interaction of the pneumococcal surface protein SpsA with the human polymeric immunoglobulin receptor (hpIgR). Indian J. Med. Res. 119, Suppl: 61-65.
36. Feldman, C., Munro, N.C., Jeffery, P.K., Andrew, P.W., Boulnois, G.J., Guerreiro, D., Rhode, J.A.L., Todd, H.C., Cole, P.J., and Wilson, R. 1991. Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo. Amer. J. Respir. Cell Mol. Biol. 5, 416-423.
37. Gor, D.O., Ding, X., Li, Q., Schreiber, J.R., Dubinsky, M., and Greenspan, N.S. 2002. Enhanced immunogenicity of pneumococcal surface adhesin A by genetic fusion to cytokines and evaluation of protective immunity in mice. Infect. Immun. 70, 5589-5595.
38. Green, B.A., Zhang, Y., Masi, A.W., Barniak, V., Wetherell, M., Smith, R.P., Reddy, M.S., and Zhu, D. 2005. PppA, a surface-exposed protein of Streptococcus pneumoniae, elicits cross-reactive antibodies that reduce colonization in a murine intranasal immunization and challenge model. Infect. Immun. 73, 981-989.
39. Hamel, J., Charland, N., Pineau, I., Ouellet, C., Rioux, S., Martin, D., and Brodeur,B.R. 2004. Prevention of pneumococcal disease inmice immunized with conserved surface-accessible proteins. Infect. Immun. 72, 2659-2670.
40. Hammerschmidt, S., Talay, S.R., Brandtzaeg, P., and Chhatwal, G.S. 1997. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol. Microbiol. 25, 1113-1124.
41. Hammerschmidt, S., Tillig, M.P., Wolff, S., Vaerman, J.P., and Chhatwal, G.S. 2000. Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif. Mol. Microbiol. 36, 726-736.
42. Iannelli, F., Oggioni, M.R., and Pozzi, G. 2002. Allelic variation in the highly polymorphic locus pspC of Streptococcus pneumoniae. Gene. 284, 63-71.
43. Jacobs, T., Cima-Cabal, M.D., Darji, A., Mendez, F.J., Vazquez, F., Jacobs, A.A., Shimada, Y., Ohno-Iwashita, Y.,Weiss, S., and de, Jr., I.T. 1999. The conserved undecapeptide shared by thiol-activated cytolysins is involved in membrane binding. FEBS Lett. 459, 463-466.
44. Janulczyk, R., Iannelli, F., Sjoholm, A.G., Pozzi, G., and Bjorck, L. 2000. Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function. J. Biol. Chem. 275, 37257-37263.
45. Jedrzejas, M.J. 2001. Pneumococcal virulence factors: Structure and function. Microbiol. Mol. Biol Rev. 65, 187-207.
46. Johnston, J.W., Myers, L.E., Ochs, M.M., Benjamin Jr., W.H., Briles, D.E., and Hollingshead, S.K. 2004. Lipoprotein PsaA in virulence of Streptococcus pneumoniae: Surface accessibility and role in protection from superoxide. Infect. Immun. 72, 5858-5867.
47. Jomaa, M., Yuste, J., Paton, J.C., Jones, C., Dougan, G., and Brown, J.S. 2005. Antibodies to the iron uptake ABC transporter lipoproteins PiaA and PiuA promote opsonophagocytosis of Streptococcus pneumoniae. Infect. Immun. 73, 6852-6859.
48. Kaijalainen, T., Rintamaki, S., Herva, E., and Leinonen, M. 2002. Evaluation of gene-technological and conventional methods in the identification of Streptococcus pneumoniae. J. Microbiol. Methods. 51, 111-118.
49. Kaplan, S.L., Mason Jr., E.O., Wald, E.R., Schutze, G.E., Bradley, J.S., Tan, T.Q., Hoffman, J.A., Givner, L.B., Yogev, R., and Barson, W.J. 2004. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 113, 443-449.
50. Kim, J.O., and Weiser, J.N. 1998. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J. Infect. Dis. 177, 368-377.
51. King, S.J., Whatmore, A.M., and Dowson, C.G. 2005. NanA, a neuraminidase from Streptococcus pneumoniae, shows high levels of sequence diversity, at least in part through recombination with Streptococcus oralis. J. Bacteriol. 187, 5376-5386.
52. Kuo, J., Douglas,M., Ree, H.K., and Lindberg, A.A. 1995. Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugated vaccines. Infect. Immun. 63, 2706-2713.
53. Lawrence, M.C., Pilling, P.A., Epa, V.C., Berry, A.M., Ogunniyi, A.D., and Paton, J.C. 1998. The crystal structure of pneumococcal surface antigen PsaA reveals a metal-binding site and a novel structure for a putative ABC-type binding protein. Structure. 6, 1553-1561.
54. Lock, R.A., Hansman, D., and Paton, J.C. 1992. Comparative efficacy of autolysin and pneumolysin as immunogens protectingmice against infection by Streptococcus pneumoniae. Microb. Pathog. 12, 137-143.
55. Lock, R.A., Paton, J.C., and Hansman, D. 1988. Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniae. Microb. Pathog. 5, 461-467.
56. Long, J.P., Tong, H.H., and DeMaria, T.F. 2004. Immunization with native or recombinant Streptococcus pneumoniae neuraminidase affords protection in the chinchilla otitis media model. Infect. Immun. 72, 4309-4313.
57. Mbelle, N., Huebner, R.E., Wasas, A.D., Kimura, A., Chang, I., and Klugman, K.P. 1999. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J. Infect. Dis. 180, 1171-1176.
58. McDaniel, L.S., McDaniel, D.O., Hollingshead, S.K., and Briles, D.E. 1998. Comparison of the PspA sequence from Streptococcus pneumoniae EF5668 to the previously identifie PspA sequence from strain Rx1 and ability of PspA from EF5668 to elicit protection against pneumococci of different capsular types. Infect. Immun. 66, 4748-4754.
59. McDaniel, L.S., Ralph, B.A., McDaniel, D.O., and Briles, D.E. 1994. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260. Microb. Pathog. 17, 323-337.
60. McDaniel, L.S., Scott, G., Kearney, J.F., and Briles, D.E. 1984. Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J. Exp. Med. 160, 386-397.
61. McDaniel, L.S., Scott, G.,Widenhofer, K., Carroll, J.M., and Briles, D.E. 1986. Analysis of a surface protein of Steeptococcus pneumoniae recognised by protective monoclonal antibodies. Microb. Pathog. 1, 519-531.
62. McDaniel, L.S., Sheffield, J.S., Delucchi, P., and Briles, D.E. 1991. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type. Infect. Immun. 59, 222-228.
63. Michon, F., Fusco, P.C., Minetti, C.A., Laude-Sharp, M., Uitz, C., Huang, C.H., D'Ambra, A.J., Moore, S., Remeta, D.P., Heron, I., and Blake, M.S. 1998. Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein. Vaccine. 16, 1732-1741.
64. Mitchell, T.J., Andrew, P.W., Saunders, F.K., Smith, A.N., and Boulnois, G.J. 1991. Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol. Microbiol. 5, 1883-1888.
65. Mollerach,M., Regueira, M., Bonofiglio, L., Callejo, R., Pace, J., Di Fabio, J.L., Hollingshead, S., and Briles, D. 2004. Invasive Streptococcus pneumoniae isolates from Argentinian children: Serotypes, families of pneumococcal surface protein A (PspA) and genetic diversity. Epidemiol. Infect. 132, 177-184.
66. Navarre, W.W., and Schneewind, O. 1994. Proteolytic cleavage and cell wall anchoring at the LPXTG motif of surface proteins in gram-positive bacteria. Mol. Microbiol. 14, 115-121.
67. Navarre, W.W., and Schneewind, O. 1999. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol. Mol. Biol. Rev. 63, 174-229.
68. Novak, R., Braun, J.S., Charpentier, E., and Tuimanen, E. 1998. Penicillin tolerance genes of Streptococcus pneumoniae: The ABC-type manganese permease complex PsaA. Mol. Microbiol. 29, 1285-1296.
69. O'Brien, K.L., and Santosham, M. 2004. Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases. Am. J. Epidemiol. 159, 634-644.
70. Ogunniyi, A.D., Folland, R.L., Briles, D.E., Hollingshead, S.K., and Paton, J.C. 2000. Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae. Infect. Immun. 68, 3028-3033.
71. Ogunniyi, A.D., Woodrow, M.C., Poolman, J.T., and Paton, J.C. 2001. Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. Infect. Immun. 69, 5997-6003.
72. Orihuela, C.J., Gao, G., Francis, K.P., Yu, J., and Tuomanen, E.I. 2004. Tissuespecific contributions of pneumococcal virulence factors to pathogenesis. J. Infect. Dis. 190, 1661-1669.
73. Paton, J.C., and Ferrante, A. 1983. Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect. Immun. 41, 1212-1216.
74. Paton, J.C., Lock, R.A., Lee, C.J., Li, J.P., Berry, A.M., Mitchell, T.J., Andrew, P.W., Hansman, D., and Boulnois, G.J. 1991. Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect. Immun. 59, 2297-2304.
75. Pilling, P.A., Lawrence, M.C., Berry, A.M., Ogunniyi, A.D., Lock, R.A., and Paton, J.C. 1998. Expression, purification and preliminary X-ray crystallographic analysis of PsaA, a putative metal-transporter protein of Streptococcus pneumoniae. Acta Crystallogr. D. Biol. Crystallogr. 54, 1464-1466.
76. Rapola, S., Kilpi, T., Lahdenkari, M., Makela, P.H., and Kayhty, H. 2001a. Antibody response to the pneumococcal proteins pneumococcal surface adhesin A and pneumolysin in children with acute otitis media. Pediatr. Infect. Dis. J. 20, 482-487.
77. Rapola, S., Kilpi, T., Lahdenkari, M., Takala, A.K., Makela, P.H., and Kayhty, H. 2001b. Do antibodies to pneumococcal surface adhesin A prevent pneumococcal involvement in acute otitis media? J. Infect. Dis. 184, 577-581.
78. Ren, B., Szalai, A.J., Hollingshead, S.K., and Briles, D.E. 2004. Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface. Infect. Immun. 72, 114-122.
79. Roche, H., Hakansson, A., Hollingshead, S.K., and Briles, D.E. 2003. Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model. Infect. Immun. 71, 1033-1041.
80. Romero-Steiner, S., Libutti, D., Pais, L.B., Dykes, J., Anderson, P., Whitin, J.C., Keyserling, H.L., and Carlone, G.M. 1997. Standardization of an opsonophagocytic assay for the measurement of functional antibidy activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin. Diagn. Lab. Immunol. 4, 415-422.
81. Romero-Steiner, S., Pilishvili, T., Sampson, J.S., Johnson, S.E., Stinson, A., Carlone, G.M., and Ades, E.W. 2003. Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies. Clin. Diagn. Lab Immunol. 10, 246-251.
82. Rosenow, C., Ryan, P., Weiser, J.N., Johnson, S., Fontan, P., Ortqvist, A., and Masure, H.R. 1997. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol. Microbiol. 25, 819-829.
83. Rossjohn, J., Gilbert, R.J., Crane, D., Morgan, P.J., Mitchell, T.J., Rowe, A.J., Andrew, P.W., Paton, J.C., Tweten, R.K., and Parker, M.W. 1998. The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae. J. Mol. Biol. 284, 449-461.
84. Russell, H., Tharpe, J.A., Wells, D.E., White, E.H., and Johnson, J.E. 1990. Monoclonal antibody recognizing a species-specific protein from Streptococcus pneumoniae. J. Clin. Microbiol. 28, 2191-2195.
85. Sampson, J.S., O'Connor, S.P., Stinson, A.R., Tharpe, J.A., and Russell, H. 1994. Cloning and nucleotide sequence analysis of psaA the Streptococcus pneumoniae gene encoding a 37-kilodalton protein homologous to previously reported Streptococcus sp. adhesins. Infect. Immun. 62, 319-324.
86. Saukkoriipi, A., Palmu, A., Kilpi, T., and Leinonen, M. 2002. Real-time quantitative PCR for the detection of Streptococcus pneumoniae in the middle ear fluid of children with acute otitis media. Mol. Cell Probes. 16, 385-390.
87. Saunders, F.K., Mitchell, T.J., Walker, J.A., Andrew, P.W., and Boulnois, G.J. 1989. Pneumolysin, the thio-activated toxin of Streptococcus pneumoniae, does not require a thio group for in vitro activity. Infect. Immun. 57, 2547-2552.
88. Schneewind, O., Mihaylova-Petkov, D., and Model, P. 1993. Cell wall sorting signals in surface proteins of gram-positive bacteria. EMBO J. 12, 4803-4811.
89. Seo, J.Y., Seong, S.Y., Ahn, B.Y., Kwon, I.C., Chung, H., and Jeong, S.Y. 2002. Cross-protective immunity of mice induced by oral immunization with pneumococcal surface adhesin A encapsulated in microspheres. Infect. Immun. 70, 1143-1149.
90. Shaper, M., Hollingshead, S.K., Benjamin Jr., W.H., and Briles, D.E. 2004. PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of Pneumococci by apolactoferrin. Infect. Immun. 72, 5031-5040.
91. Sheppard, C.L., Harrison, T.G., Morris, R., Hogan, A., and George, R.C. 2004. Autolysin-targeted LightCycler assay including internal process control for detection of Streptococcus pneumoniae DNA in clinical samples. J. Med. Microbiol. 53, 189-195.
92. Simell, B., Korkeila, M., Pursiainen, H., Kilpi, T.M., and Kayhty, H. 2001. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin A, pneumolysin, and pneumococcal surface protein a in children. J. Infect. Dis. 183, 887-896.
93. Smart, L.E., Dougall, A.J., and Girdward, R.W.A. 1987. New 23-valent pneumococcal vaccine in relation to pneumococcal serotypes in systemic and systemic disease. J. Infect. 14, 209-215.
94. Steinfort, C., Wilson, R., Rutman, A., Sykes, D., Todd, H., Walker, J., Mitchell, T., Saunders, K., Andrew, P., Boulnois, G., and Cole, P. 1989. Pneumolysin produced by Streptococcus pneumoniae damages human respiratory epithelium in vitro. Chest 95 Suppl, 221S.
95. Tai, S.S., Lee, C.-J., and Winter, R.E. 1993. Hemin utilization is related to virulence of Streptococcus pneumoniae. Infect. Immun. 61, 5401-5405.
96. Tai, S.S., Yu, C., and Lee, J.K. 2003. A solute binding protein of Streptococcus pneumoniae iron transport. FEMS Microbiol. Lett. 220, 303-308.
97. Talkington, D.F., Brown, B.G., Tharpe, J.T., Koenig, A., and Russell, H. 1996. Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin (PsaA). Microb. Pathog. 21, 17-22.
98. Talkington, D.F., Crimmins, D.L., Voellinger, D.C., Yother, J., and Briles, D.E. 1991. A 43-kilodalton pneumococcal surface protein, PspA: Isolation, protective abilities, and structural analysis of the amino-terminal sequence. Infect. Immun. 59, 1285-1289.
99. Tart, R.C., McDaniel, L.S., Ralph, B.A., and Briles, D.E. 1996. Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice. J. Infect. Dis. 173, 380-386.
100. Tong, H.H., Blue, L.E., James, M.A., and DeMaria, T.F. 2000. Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase- deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect. Immun. 68, 921-924.
101. Tong, H.H., James, M., Grants, I., Liu, X., Shi, G., and DeMaria, T.F. 2001. Comparison of structural changes of cell surface carbohydrates in the eustachian tube epithelium of chinchillas infected with a Streptococcus pneumoniae neuraminidase-deficient mutant or its isogenic parent strain. Microb. Pathog. 31, 309-317.
102. Tong, H.H., McIver,M.A., Fisher, L.M., andDeMaria, T.F. 1999. Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium. Microb. Pathog. 26, 111-119.
103. Usobiaga, P., Medrano, F.J., Gasset, M., Garcia, J.L., Saiz, J.L., Rivas, G., Laynez, J., and Menendez, M. 1996. Structural organization of the major autolysin from Streptococcus pneumoniae. J. Biol. Chem. 271, 6832-6838.
104. Vela Coral, M.C., Fonseca, N., Castaneda, E., Di Fabio, J.L., Hollingshead, S.K., and Briles, D.E. 2001. Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children. Emerg. Infect. Dis. 7, 832-836.
105. Weiser, J.N., Austrian, R., Sreenivasan, P.K., and Masure, H.R. 1994. Phase variation in pneumococcal opacity: Relationship between colonial morphology and nasopharyngeal colonization. Infect. Immun. 62, 2582-2589.
106. Wizemann, T.M., Heinrichs, J.H., Adamou, J.E., Erwin, A.L., Kunsch, C., Choi, G.H., Barash, S.C., Rosen, C.A., Masure, H.R., Toumanen, E., Gayle, A., Brewah, Y.A., Walsh, W., Barren, P., Lathigra, R., Hanson, M., Langermann, S., Johnson, S., and Kogoma, T. 2001. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect. Immun. 69, 1593-1598.
107. Wortham, C., Grinberg, L., Kaslow, D.C., Briles, D.E., McDaniel, L.S., Lees, A., Flora, M., Snapper, C.M., and Mond, J.J. 1998. Enhanced protective antibody responses to PspA after intranasal or subcutaneous injections of PspA genetically fused to granulocyte-macrophage colony-stimulating factor or interleukin-2. Infect. Immun. 66, 1513-1520.
108. Yamamoto, M., McDaniel, L.S., Kawabata, K., Briles, D.E., Jackson, R., McGhee, J.R., and Kiyono, H. 1997. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection. Infect. Immun. 65, 640-644.
109. Yother, J., and Briles, D.E. 1992. Structural properties and evolutionay relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis. J. Bacteriol. 174, 601-609.
110. Yother, J., and White, J.M. 1994. Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspA. J. Bacteriol. 176, 2976-2985.
111. Zhang, J.R., Mostov, K.E., Lamm, M.E., Nanno, M., Shimida, S., Ohwaki, M., and Tuomanen, E. 2000. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell. 102, 827-837.
112. Zhang, Y., Masi, A.W., Barniak, V., Mountzouros, K., Hostetter, M.K., and Green, B.A. 2001. Recombinant PhpA protein, a unique histidine motifcontaining protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge. Infect. Immun. 69, 3827-3836.